Alyeska Investment Group, L.P. - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,736,000
+80.3%
99,421
+98.9%
0.02%
+66.7%
Q3 2020$963,000
-44.0%
49,978
-43.5%
0.02%
-42.3%
Q2 2020$1,720,000
-15.7%
88,384
-39.3%
0.03%
-36.6%
Q1 2020$2,040,000
+207.2%
145,711
+438.1%
0.04%
+355.6%
Q4 2019$664,000
-12.2%
27,080
-64.0%
0.01%
-18.2%
Q3 2019$756,00075,1770.01%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders